NovoCure Limited

NovoCure Limitedverified

NVCR

Price:

$17.96

Market Cap:

$1.94B

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, ...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2015-10-01

Stock Exchange

NASDAQ

Ticker

NVCR

The ROE as of September 2024 (TTM) for NovoCure Limited (NVCR) is -45.68%

According to NovoCure Limited’s latest financial reports and current stock price. The company's current ROE is -45.68%. This represents a change of 300.96% compared to the average of -11.39% of the last 4 quarters.

NovoCure Limited (NVCR) Historical ROE (quarterly & annually)

How has NVCR ROE performed in the past?

The mean historical ROE of NovoCure Limited over the last ten years is -42.19%. The current -45.68% ROE has changed 8.26% with respect to the historical average. Over the past ten years (40 quarters), NVCR's ROE was at its highest in in the September 2020 quarter at 3.02%. The ROE was at its lowest in in the March 2015 quarter at -30.46%.

Quarterly (TTM)
Annual

Average

-42.19%

Median

-49.39%

Minimum

-92.62%

Maximum

4.16%

NovoCure Limited (NVCR) ROE by Quarter and Year

Discovering the peaks and valleys of NovoCure Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 172.31%

Maximum Annual ROE = 4.16%

Minimum Annual Increase = -441.97%

Minimum Annual ROE = -92.62%

Quarterly (TTM)
Annual
YearROEChange
2023-57.12%172.31%
2022-20.97%47.55%
2021-14.21%-441.97%
20204.16%-225.21%
2019-3.32%-94.14%
2018-56.62%4.27%
2017-54.30%-41.38%
2016-92.62%108.21%
2015-44.49%-46.03%
2014-82.43%83.02%

NovoCure Limited (NVCR) Average ROE

How has NVCR ROE performed in the past?

The current ROE of NovoCure Limited (NVCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-30.77%

5-year avg

-18.29%

10-year avg

-42.19%

NovoCure Limited (NVCR) ROE vs. Peers

How is NVCR’s ROE compared to its peers?

NovoCure Limited’s ROE is less than Globus Medical, Inc. (0%), less than Insulet Corporation (1.01%), less than Inspire Medical Systems, Inc. (50.53%), less than Inari Medical, Inc. (1.03%), greater than TransMedics Group, Inc. (-12.76%), less than InMode Ltd. (1.96%), less than Integer Holdings Corporation (19.39%), less than CONMED Corporation (6.95%), less than LivaNova PLC (11.71%), greater than iRhythm Technologies, Inc. (-1.33%), greater than Heska Corporation (-84.98%), greater than ShockWave Medical, Inc. (-3.24%), less than Penumbra, Inc. (24.79%), less than Masimo Corporation (1.22%), less than null (5.91%),

Build a custom stock screener for NovoCure Limited (NVCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovoCure Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovoCure Limited (NVCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovoCure Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is NovoCure Limited's ROE?

How is the ROE calculated for NovoCure Limited (NVCR)?

What is the highest ROE for NovoCure Limited (NVCR)?

What is the 3-year average ROE for NovoCure Limited (NVCR)?

What is the 5-year average ROE for NovoCure Limited (NVCR)?

How does the current ROE for NovoCure Limited (NVCR) compare to its historical average?